Finding your next opportunity shouldn’t require piecing together multiple databases, alerts and research tools.
Fundz combines its own funding and M&A intelligence with hiring, leadership and other business signals into one connected view of each company, ranks opportunities against your ideal customer profile, and delivers the evidence and verified contacts to act on. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
OracleSnowflakeCloudflareLinkedInGoogleSalesforce
★★★★★4.8/5 on G2· Since 2015
CSL Limited announces a global partnership with Alentis Therapeutics for the co-development of lixudebart.
Oct 06, 2026
Contract Type
partnership
BiotechnologyHealth Care
Description
CSL Limited and Alentis Therapeutics have entered an exclusive global partnership to co-develop lixudebart, a therapy targeting claudin-1 for rare kidney and liver diseases. CSL will make an initial payment of $355 million and will fund further clinical development.
Company Information
Company
CSL Limited
About
CSL Limited is a global biotechnology company that develops and delivers innovative medicines. The company specializes in treating patients with serious and rare diseases. CSL operates in more than 35 countries worldwide.
Predictive Intelligence
Strategic
ML-powered predictions for CSL Limited's next move